Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2037
Source ID: NCT03125694
Associated Drug: Sitagliptin 100mg
Title: Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Uncontrolled Type 2 Diabetes Mellitus
Interventions: DRUG: Sitagliptin 100mg|DRUG: Pioglitazone 30 mg
Outcome Measures: Primary: Change from baseline in mean glycated hemoglobin (A1C) levels by sitagliptin vs. pioglitazone, 52 weeks |
Sponsor/Collaborators: Sponsor: Tehran University of Medical Sciences
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 250
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2015-02-01
Completion Date: 2017-04-01
Results First Posted:
Last Update Posted: 2017-04-24
Locations: Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of
URL: https://clinicaltrials.gov/show/NCT03125694